Skip to main content
JUBILANT PHARMOVA LIMITED logo

JUBILANT PHARMOVA LIMITED — Investor Relations & Filings

Ticker · JUBLPHARMA ISIN · INE700A01033 LEI · 335800C6LDKWF4HQH833 BSE.NS Manufacturing
Open in API
Filings indexed 1,045 across all filing types
Latest filing 2024-07-10 Regulatory Filings
Country IN India
Listing BSE.NS JUBLPHARMA

About JUBILANT PHARMOVA LIMITED

https://www.jubilantpharmova.com/

Jubilant Pharmova Limited is an integrated global pharmaceutical company operating through three primary segments: Pharmaceuticals, Contract Research and Development Services (CRDS), and Proprietary Novel Drugs. The Pharmaceuticals segment specializes in radiopharmaceuticals for nuclear medicine, allergy immunotherapy, and the development and manufacturing of generic formulations. It also provides Contract Development and Manufacturing Organization (CDMO) services for sterile injectables and non-sterile products. The CRDS division offers comprehensive drug discovery and development solutions to biopharmaceutical companies worldwide. Furthermore, the Proprietary Novel Drugs segment focuses on creating innovative therapies for oncology and autoimmune diseases. The company leverages its advanced manufacturing infrastructure and research capabilities to serve global markets with a focus on complex chemistry and specialized healthcare solutions.

Recent filings

Filing Released Lang Actions
Board Meeting — JUBILANT PHARMOVA LIMITED has informed the Exchange about Board Meeting to be held on 19-Jul-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for…
Regulatory Filings
2024-07-10 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short notice informing about a scheduled Board Meeting on July 19, 2024, to consider the unaudited financial results for the quarter ended June 30, 2024. It references Regulation 29 of the SEBI Listing Obligations and Disclosure Requirements, which governs disclosures related to board meetings. The document does not contain any financial data or results itself, nor does it include detailed financial analysis or reports. It is an announcement of an upcoming event (board meeting) rather than the meeting minutes or financial results. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories. The document length is short (1241 characters), supporting that it is an announcement rather than a full report.
2024-07-10 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming details related to shareholding or depository participant activities for the quarter ended June 30, 2024. It is a short letter addressed to stock exchanges and does not contain financial statements or detailed financial data. It is primarily a regulatory compliance certificate rather than a full report or announcement of financial results. Therefore, it fits best under Regulatory Filings (RNS) as it is a compliance document and not a financial report or announcement of a report.
2024-07-09 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the outcome of a postal ballot. It references Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to voting results. The content includes detailed voting results for special resolutions such as re-appointment and appointment of directors. The document includes the Scrutinizer's Report and voting details, indicating it is an official announcement of voting results rather than the meeting materials or proxy statements. The document length is about 15,000 characters, which is consistent with a detailed voting result announcement. There is no indication that this is a proxy solicitation, management report, or AGM presentation. Therefore, the document best fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-06-26 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding compliance with SEBI regulations about a lost share certificate. It informs about the loss of a share certificate and the proposed issuance of a duplicate certificate. There is no financial data, no report attached or referenced as being published, and no mention of financial results or management changes. This is a regulatory compliance announcement related to share certificates and shareholder transactions, fitting best under Regulatory Filings (RNS). The document length is short and it is not a report itself but a notification.
2024-06-25 English
Updates
Capital/Financing Update Classification · 95% confidence The document is an announcement dated June 25, 2024, regarding the completion of a voluntary prepayment of a USD 75 million term loan by Jubilant Pharma Holdings Inc., a subsidiary of Jubilant Pharmova Limited. It references an earlier communication on June 14, 2024, and provides details about the debt position as of March 31, 2024. The document is relatively short (6020 characters) and primarily serves to inform stakeholders about a financing activity (loan prepayment). There are no financial statements, detailed financial analysis, or comprehensive report content. The nature of the announcement is about a capital structure change (loan prepayment), which fits the category of Capital/Financing Update (CAP). It is not an annual or interim report, earnings release, or regulatory filing. Therefore, the appropriate classification is CAP with high confidence.
2024-06-25 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.